IGP DECLARES OPEN 2025 NIGERIA POLICE PUBLIC RELATIONS OFFICERS’ CONFERENCE. (PHOTOS). #PRESS RELEASE.

Image
 IGP DECLARES OPEN 2025 NIGERIA POLICE PUBLIC RELATIONS OFFICERS’ CONFERENCE …Tasks PPROs on strategic communication, combating misinformation The Inspector-General of Police, IGP Kayode Adeolu Egbetokun, Ph.D., NPM, on Monday, December 8, 2025, declared open the 2025 Annual Conference of Police Public Relations Officers (PPROs) of the Nigeria Police Force, held at the Police Resource Centre, Abuja. In his keynote address, the IGP described the annual conference as “a strategic national engagement and a critical platform for strengthening police-public communication, shaping national narratives constructively, and deepening trust between the Police and citizens.” He emphasised that modern-day policing is increasingly defined by public trust, transparency, and the quality of communication between law enforcement agencies and the public, noting that the Public Relations Officers remain central to institutional credibility. The IGP highlighted the growing challenge of misinformation, ...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.